NVAX
NASDAQ · Biotechnology
Novavax Inc
$8.03
-0.01 (-0.12%)
Open$8.03
Previous Close$8.04
Day High$8.36
Day Low$7.96
52W High$11.97
52W Low$5.80
Volume—
Avg Volume4.93M
Market Cap1.56B
P/E Ratio3.55
EPS$2.37
SectorBiotechnology
Analyst Ratings
Buy
15 analysts
Price Target
+259.7% upside
Current
$8.03
$8.03
Target
$28.88
$28.88
$20.35
$28.88 avg
$29.25
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.26B | 1.53B | 441.16M |
| Net Income | 494.83M | 538.12M | -6,729,988 |
| Profit Margin | 39.2% | 37.2% | -1.5% |
| EBITDA | 553.29M | 635.12M | -8,036,743 |
| Free Cash Flow | — | — | -9,195,591 |
| Rev Growth | -17.2% | -17.2% | +6.7% |
| Debt/Equity | 0.75 | 0.75 | 0.98 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $201.55 | -0.57% | 88.1 | 372.29B |
| AMGN | Amgen Inc | $331.70 | +0.79% | 22.7 | 176.88B |
| GILD | Gilead Sciences Inc | $131.33 | -2.04% | 19.3 | 163.92B |
| VRTX | Vertex Pharmaceuticals Inc | $429.82 | +1.13% | 27.7 | 109.50B |
| REGN | Regeneron Pharmaceuticals | $714.89 | +0.82% | 16.5 | 74.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $295.05 | -0.29% | 130.4 | 40.90B |